Xiangxue Pharmaceutical Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 1, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Market Capitalization	6,633	6,018	6,461	3,406	3,961	5,266
Market Cap Growth	62.82%	-6.86%	89.71%	-14.02%	-24.79%	-9.85%
Enterprise Value	8,312	8,515	9,128	6,159	6,816	9,064
Last Close Price	10.03	9.10	9.77	5.15	6.07	8.07
Forward PE	-	11.93	11.93	11.93	11.93	11.93
PS Ratio	4.16	3.77	3.48	1.48	1.81	1.77
PB Ratio	150.93	136.93	4.49	1.47	1.46	1.40
P/TBV Ratio	-	-	437.03	4.23	3.47	3.20
P/FCF Ratio	56.15	50.95	-	16.42	-	-
P/OCF Ratio	47.50	43.10	355.48	12.93	17.42	20.45
EV/Sales Ratio	5.21	5.34	4.91	2.68	3.12	3.05
EV/EBITDA Ratio	57.42	74.92	-	21.82	113.06	72.50
EV/EBIT Ratio	-	-	-	123.98	-	-
EV/FCF Ratio	70.37	72.09	-	29.69	-	-
Debt / Equity Ratio	33.38	33.38	1.56	1.05	0.90	0.92
Debt / EBITDA Ratio	10.13	10.13	-	8.48	38.38	27.04
Debt / FCF Ratio	12.42	12.42	-	11.73	-	-
Net Debt / Equity Ratio	27.59	27.59	1.46	0.99	0.84	0.82
Net Debt / EBITDA Ratio	10.67	10.67	-133.61	8.09	38.01	24.64
Net Debt / FCF Ratio	10.26	10.26	-122.94	11.01	-16.38	-10.10
Asset Turnover	0.22	0.22	0.24	0.27	0.22	0.25
Inventory Turnover	3.64	3.64	3.86	3.54	2.69	2.78
Quick Ratio	0.18	0.18	0.19	0.19	0.18	0.28
Current Ratio	0.26	0.26	0.30	0.35	0.32	0.44
Return on Equity (ROE)	-184.89%	-184.89%	-45.91%	-15.96%	-15.58%	-16.45%
Return on Assets (ROA)	-0.67%	-0.67%	-1.85%	0.37%	-1.09%	-0.12%
Return on Invested Capital (ROIC)	-3.45%	-3.20%	-5.75%	1.03%	-2.96%	-0.31%
Return on Capital Employed (ROCE)	-13.30%	-13.30%	-11.10%	1.60%	-5.10%	-0.50%
Earnings Yield	-20.99%	-23.14%	-13.29%	-11.42%	-13.38%	-13.07%
FCF Yield	1.78%	1.96%	-0.26%	6.09%	-3.53%	-5.79%
Buyback Yield / Dilution	0.10%	0.10%	-0.18%	0.50%	-0.09%	-0.89%
Total Shareholder Return	0.10%	0.10%	-0.18%	0.50%	-0.09%	-0.89%